Biogen reported $1.08B in EBITDA for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -33.14M 79.36M
Acorda Therapeutics ACOR:US $ -6.2M 1.23M
ALKERMES ALKS:US $ -15.07M 7.68M
Amgen AMGN:US $ 3004M 337M
Bayer BAYN:GR € 4762M 490M
Biogen BIIB:US $ 1075.7M 401M
Biomarin Pharmaceutical BMRN:US $ 64.42M 7.75M
Bluebird Bio BLUE:US $ -99.42M 19.92M
Bristol Myers Squibb BMY:US $ 5780M 8M
Eli Lilly And LLY:US $ 1999.4M 1006.2M
Esperion Therapeutics ESPR:US $ -52226000 9.39M
Gilead Sciences GILD:US $ 2585M 837M
Intercept Pharmaceuticals ICPT:US $ -10.87M 0.98M
Intra Cellular Therapies ITCI:US $ -87.75M 15.26M
Marinus Pharmaceuticals MRNS:US $ -36.67M 20.05M
Moderna Inc MRNA:US 2.52B 1.78B
Neurocrine Biosciences NBIX:US $ 58.6M 52.2M
Novartis NOVN:VX SF 4660M 108M
Pfizer PFE:US $ 12921M 1739M
Ptc Therapeutics PTCT:US $ -63.18M 2.97M
Puma Biotechnology PBYI:US $ 14.28M 12.77M
Regeneron Pharmaceuticals REGN:US $ 1381.3M 20.4M
Sangamo Biosciences SGMO:US $ -42.85M 0.42M
Sarepta Therapeutics SRPT:US $ -201.24M 125.08M
Seattle Genetics SGEN:US $ -115.89M 0.06M
Teva Pharmaceutical TEVA:IT 1.09B 20M
Ultragenyx Pharmaceutical RARE:US $ -137.11M 4.57M
United Therapeutics UTHR:US $ 214.5M 86M
Vertex Pharmaceuticals VRTX:US $ 1156.6M 87.3M
YTE INCY:US $ 276.8M 132.69M